Department of Vascular Surgery - Lillebaelt Hospital
Kolding, 6000, Denmark
Location status: Recruiting
Location contact
Christina P Madsen, MD
CONTACT
Christina Pilgaard Madsen, MD
PRINCIPAL_INVESTIGATOR
Trine M M Jørgensen, MD PhD
CONTACT
NCT Number: NCT06631378
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery.
The main questions it aims to answer are:
Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate.
Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Kolding, 6000, Denmark
Location status: Recruiting
Christina P Madsen, MD
CONTACT
Christina Pilgaard Madsen, MD
PRINCIPAL_INVESTIGATOR
Trine M M Jørgensen, MD PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The transverse incision is made parallel to the inguinal ligament either superiorly or inferiorly to the skin crease directly over the femoral artery. The subcutaneous tissue is dissected in the transverse direction till Scarpaes fascia after which the dissection is performed in the longitudinal direction along the line of the vessels. The lymphatic vessels are spared as much as possible. Any damaged lymph vessels are closed with surgical clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. In case of difficulty with proper access to the femoral arteries, the incision can be extended either medially, laterally, or vertically.
The longitudinal incision is made directly over the femoral artery from the inguinal ligament. The subcutaneous tissue is dissected along the line of the vessel sparing the lymphatic vessels as much as possible. Any damaged lymph vessels are closed with clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage.
Time frame: 35 days after the operation
The surgical site complications are defined as follows:
Time frame: 35 days after the operation
Reoperation in the groin due to surgical site complications Reoperation due to the reconstruction Minor or major amputation
Time frame: 35 days
Is the patient readmitted due to either surgical site complications or for other reasons
Time frame: 35 days
The duration of the hospital stay after the operation.
Time frame: 35 days
Death and the cause of death.
Time frame: 35 days
Evaluation of the groin to access if it has healed irrespective of the development of surgical site complications.
Contact information is provided by the study sponsor or research team.
Kolding Sygehus
Other
The Incidence of Surgical Site Complications in Transverse Versus Longitudinal Groin Incision in Vascular Surgery: A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06979284
Arterial Occlusive Diseases, Arteriosclerosis
Hamilton, Canada
View Trial DetailsNCT07157475
Arterial Occlusive Diseases, Arteriosclerosis
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial DetailsNCT07016698
Arterial Occlusive Diseases, Arteriosclerosis
Lakeland, Florida, United States
View Trial DetailsNCT07097857
Arterial Occlusive Diseases, Arteriosclerosis
Singapore, SG
View Trial Details